Editas Medicine (EDIT) Other Non-Current Assets (2015 - 2025)

Editas Medicine (EDIT) has reported Other Non-Current Assets for 11 consecutive years, with $3.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non-Current Assets fell 43.02% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (down 43.02% YoY), while the FY2025 annual figure was $3.0 million, down 43.02% from the prior year.
• Other Non-Current Assets held at $3.0 million in Q4 2025 per EDIT's latest filing, from $3.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $9.5 million in Q1 2024 and bottomed at $3.0 million in Q4 2025.
• Historically, Other Non-Current Assets has averaged $6.2 million across 5 years, with a median of $6.7 million in 2021.
• Annual changes were most pronounced in 2021 — Other Non-Current Assets soared 179.72% — and 2025, when it slumped 55.75%.
• Editas Medicine's Other Non-Current Assets stood at $6.8 million in 2021, then dropped by 22.87% to $5.3 million in 2022, then surged by 63.49% to $8.6 million in 2023, then tumbled by 39.18% to $5.2 million in 2024, then plunged by 43.02% to $3.0 million in 2025.
• Business Quant data shows EDIT's Other Non-Current Assets at $3.0 million in Q4 2025, $3.0 million in Q3 2025, and $4.2 million in Q2 2025.